Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Liu HuiOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,000,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Kucinski Keith AOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,000,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Jabbour Jerome DOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,500,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Hoover ThomasOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,000,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Ferguson James J. IIIOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,200,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Matkovits TheresaOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,300,000Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Giordano NatashaOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Wikler MatthewOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Corzo Kathryn PenkusOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Scibetta James SOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
Filings by filing date
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Liu HuiOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,000,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Kucinski Keith AOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,000,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Jabbour Jerome DOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:3,500,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Hoover ThomasOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,000,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Ferguson James J. IIIOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,200,000Price:--
-
Dec 15, 2023 (filed on Dec 15, 2023)Insider Name:Matkovits TheresaOwnership Type:Direct OwnershipSecurities:Stock Option (right to Buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:1,300,000Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Giordano NatashaOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Wikler MatthewOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Corzo Kathryn PenkusOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
-
Nov 01, 2023 (filed on Nov 03, 2023)Insider Name:Scibetta James SOwnership Type:Direct OwnershipSecurities:Stock option (right to buy)Nature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:437,244Price:--
News
Biz Brief
Sector: Healthcare | Industry: Biotechnology & Medical Research |
See Regulatory Filings on SEC |
Company Contact | |
Address: | Suite 302, 1545 Route 206 South BEDMINSTER NJ 07921 |
Tel: | 1-310-6917100 |
Website: | https://www.matinasbiopharma.com |
IR: | See website |
Key People | ||
Jerome D. Jabbour President, Chief Executive Officer, Director | Keith A. Kucinski Chief Financial Officer | Hui Liu Chief Technology Officer |
James J. Ferguson Chief Medical Officer | Thomas J. Hoover Chief Business Officer | Theresa Matkovits Chief Development Officer |
Business Overview |
N/A |
Financial Overview |
For the fiscal year ended 31 December 2023, Matinas BioPharma Holdings Inc revenues decreased 66% to $1.1M. Net loss increased 9% to $22.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Higher net loss reflects Sale of New Jersey net operating loss decrease of 86% to $484K (income). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.10 to -$0.11. |
Employees: | 32 as of Mar 18, 2024 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $32.07M as of Dec 31, 2023 |
Annual revenue (TTM): | $1.10M as of Dec 31, 2023 |
EBITDA (TTM): | -$23.37M as of Dec 31, 2023 |
Net annual income (TTM): | -$22.94M as of Dec 31, 2023 |
Free cash flow (TTM): | -$15.29M as of Dec 31, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 250,816,164 as of Apr 2, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |